FDAnews Device Daily Bulletin

VIACELL FINALIZES IDE AND ANNOUNCES PLANS TO COMMENCE CLINICAL TRIAL OF VIACYTE IN OOCYTE CRYOPRESERVATION

June 28, 2006
A A

ViaCell, Incannounced today the United States Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (IDE) to evaluate its ViaCyte(SM) investigational product offering for the cryopreservation and thawing of human oocytes for use during assisted reproductive technology.
ViaCell